HALIFAX, Nova Scotia – June 8, 2023
Adaptiiv Medical Technologies Inc. (Adaptiiv) announces the appointment of Joshua Levine as Executive Chairperson of the company’s Board, effective immediately. Mr. Levine is an accomplished healthcare executive with more than 30 years of experience transforming various healthcare-related companies.
Mr. Levine has served as a CEO and Director with 3 publicly traded, global medical device companies over the past two decades. Most recently he led Accuray Incorporated, a company that develops, manufactures, and sells radiotherapy systems. Prior to Accuray, Mr. Levine led Immucor, a diagnostics manufacturer of automated instrumentation and reagents used in blood transfusion procedures. Mr. Levine’s first CEO role was with Mentor Corporation, a surgical implant manufacturer which was the market leader in the surgical aesthetics space. Until July 2022, Mr. Levine also served as an Independent Director and non-executive Chairperson of the Board at Natus Medical Incorporated, a provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders.
Mr. Levine brings global medical device industry experience in commercial and strategic marketing leadership, business development, and general management roles spanning three decades in the medical device industry. Mr. Levine holds a B.A. from the University of Arizona.
“Josh will become an integral part of our fundraising and commercialization efforts as we look to scale the business and position Adaptiiv for future growth. Josh’s track record speaks for itself within the medical device industry,” said Adaptiiv CEO, Alex Dunphy.
“I am excited to join the Adaptiiv Board of Directors at this important moment in the company’s lifecycle. Adaptiiv’s technology is delivering meaningful and significant clinical treatment solutions to radiation therapy providers that can improve the quality and precision of treatment delivery for their patients,” said Josh Levine.
Adaptiiv Medical Technologies Inc. provides proprietary, regulatory cleared software that integrates with clinical workflows to digitally design, fabricate, and deliver patient-specific 3D printed medical devices that improve clinical precision and the patient experience. Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv software has FDA 510(k) clearance and has received a CE Mark. The company’s solution is currently used in a clinical setting by clients in 18 countries. Visit adaptiiv.com to learn more.
Media Contact
Rohit Seth
Director, Marketing
Adaptiiv Medical Technologies Inc.
Tel: 902-442-9091
rohit.seth@adaptiiv.com